These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2431221)

  • 21. Oncogene activation in malignant transformation: a study of H-ras in human breast cancer.
    Spandidos DA
    Anticancer Res; 1987; 7(5B):991-6. PubMed ID: 3435051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
    King CR; Swain SM; Porter L; Steinberg SM; Lippman ME; Gelmann EP
    Cancer Res; 1989 Aug; 49(15):4185-91. PubMed ID: 2568168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.
    Ghosh AK; Moore M; Harris M
    J Clin Pathol; 1986 Apr; 39(4):428-34. PubMed ID: 3009557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
    Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
    Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
    Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ
    Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogene structure, function, and expression in breast cancer.
    Yee LD; Kacinski BM; Carter D
    Semin Diagn Pathol; 1989 May; 6(2):110-25. PubMed ID: 2669069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.
    Going JJ; Williams AR; Wyllie AH; Anderson TJ; Piris J
    J Pathol; 1988 Jul; 155(3):185-90. PubMed ID: 3045276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transformation of human mammary epithelial cells by oncogenic retroviruses.
    Clark R; Stampfer MR; Milley R; O'Rourke E; Walen KH; Kriegler M; Kopplin J; McCormick F
    Cancer Res; 1988 Aug; 48(16):4689-94. PubMed ID: 3293776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
    Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
    Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7.
    Graham KA; Richardson CL; Minden MD; Trent JM; Buick RN
    Cancer Res; 1985 May; 45(5):2201-5. PubMed ID: 3986769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The c-K-ras gene and human cancer (review).
    Kahn S; Yamamoto F; Almoguera C; Winter E; Forrester K; Jordano J; Perucho M
    Anticancer Res; 1987; 7(4A):639-52. PubMed ID: 3310850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oncogenes in human gastric carcinoma].
    Tahara E
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of the expression of the oncogene c-myc in human breast adenocarcinoma].
    Guérin M; Lacombe MJ; Riou G
    C R Acad Sci III; 1985; 301(20):833-8. PubMed ID: 3938309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.
    Tahara E; Yasui W; Taniyama K; Ochiai A; Yamamoto T; Nakajo S; Yamamoto M
    Jpn J Cancer Res; 1986 Jun; 77(6):517-22. PubMed ID: 3089984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.